Series 8 | Episode 1: Infectious Diseases in the NICU - RSV
GUEST:
Joanne M. Langley, MD, MSc, FRCPC
Professor of Pediatrics and Community Health and Epidemiology
GSK-CIHR Chair in Pediatric Vaccinology, Dalhousie University
Head, Division of Pediatric Infectious Diseases, IWK Health
Halifax, Nova Scotia
Biography: Dr. Langley is a pediatric infectious disease physician at the IWK Health Centre in Halifax, a professor in the Faculty of Medicine at Dalhousie University, and Director of the Evaluation Group at the Canadian Center for Vaccinology. She conducts studies on the prevention of infectious diseases using vaccines, from phase 1 (first in humans) through to efficacy trials (phase 3) and post-marketing studies of how well vaccines work when they are used in immunization programs (phase 4). These studies are done with collaborators in public health, industry, universities, and non-governmental organizations.
Dr. Langley has a particular interest in prevention of respiratory infections such as Respiratory Syncytial Virus and influenza. Her work also focuses on vaccine policy and evidence-based decision making in immunization programs. She is a member of the COVID-19 Science Expert Panel, the Expert Group on Health Systems of the Chief Science Advisor of Canada, a former member of the Canadian Task Force on Preventive Health Care and Canada’s National Advisory Committee on Immunization (Chair, 2007-2011), and serves as an advisor on several immunization decision making expert groups. She is an active investigator in the Canadian Immunization Research Network and leads its Clinical Trials Network (CTN).
This podcast is sponsored by Sanofi